Skip to main content

Month: January 2023

Dividend News Update: BOTS Incorporated Announces Record Date for Dividend to All $BTZI Shareholders; Artificial Intelligence Will be Remaining Core Business Post Dividend; Scott Adams Cyborgesqe AI Reads News of His Annexation

SAN JUAN, Puerto Rico, Jan. 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BOTS, Inc. (OTC PINK: BTZI) (“The Company”), a leading provider of advanced technology solutions is excited to announce an update to its business strategy. This change will mark a significant shift in the company’s direction, positioning Bots, Inc. at the forefront of the rapidly-growing artificial intelligence and drone technology markets. As a result of transferring its blockchain-related assets to Bullet Blockchain and planning to distribute up to 250,000,000 shares of $BULT to $BTZI shareholders, Bots is transforming its business strategy, introducing a new division focused on Artificial Intelligence (AI) initially applying the same to smart Drones. Bots will shortly file a patent related to the use of AI in Drones and announce the...

Continue reading

Investeringsforeningen Investin suspenderer handel med alle afdelinger

Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen om suspension af alle fonde, som administreres af Nykredit Portefølje Administration A/S. Det skyldes, at det grundet tekniske problemer ikke er muligt at stille korrekt NAV. Suspensionen vil blive ophævet, når det igen er muligt at stille korrekte priser. Følgende afdelinger er omfattet af suspensionen:ISIN Cur Afdeling Orderbook Code CurDK0060696656 Investin Advice Capital Globale INIACGDK0060575942 Investin Aktiv Balance INIABDK0060511897 Investin Demetra INIDEMDK0060518983 Investin Optimal Mix – KL INIOMIDK0060946192 Investin Optimal Offensiv – KL INIOFFDK0060674844 Investin Optimal Active and Index – KL INIOAIDK0060518710 Investin Optimal Stabil INIOPSDK0060254712 Investin Optimal VerdensIndex Moderat INIOVMDK0061112034 Investin...

Continue reading

European Energy A/S announces expiration time of the tender offer regarding certain outstanding callable subordinated green capital securities due 3020

NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES. NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY LAW OR REGULATION APPLICABLE IN SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR ISSUE OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES. European Energy A/S announces expiration time of the tender offer regarding certain outstanding callable subordinated green capital securities due 3020 Company Announcement Company Announcement no. 2/2023 (19.01.2023) Copenhagen, 19 January 2023: Reference is made to European Energy A/S’ (the “Company”) announcement no. 1/2023 of...

Continue reading

Proactive news headlines including Cobre Ltd, Bellevue Gold, Cyclone Metals and Chimeric Therapeutics

Sydney, Jan. 19, 2023 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Cobre Ltd (ASX:CBE) has received 212 applications for a total subscription of $2.96 million in shares for the company’s share purchase plan (SPP), almost triple the original target of $1 million. Click here Bellevue Gold Ltd (ASX:BGL) is one step closer to maiden production at its namesake WA gold play after its Mining Proposal and Mine Closure Plan was approved. Click here Cyclone Metals Ltd (ASX:CLE) has received firm commitments from institutional and sophisticated investors to raise $1.35 million through a placement of fully paid ordinary shares at an issue price of $0.0025 per share. Click here Chimeric Therapeutics Ltd (ASX:CHM) has dosed the first...

Continue reading

Finnish Wellbeing Services Counties continue to choose Aino for Employee Sustainability

Another Finnish wellbeing services county has chosen Aino’s SaaS solution. The agreement contains a total of approximately 7 400 employees. Implementation is expected to take place at the end of the first quarter of 2023.   “We are very happy about the great trust in Aino and look forward to creating added value and contributing to increased Employee Sustainability within the public sector” says Jyrki Eklund, CEO Aino Health.   Aino’s SaaS solution supports managers with internal work ability-related processes and absence management. It also offers reporting and analytics tools to track key metrics related to corporate health management. The goal of the solution is to digitize preventative support processes and increase employee well-being.  For more information  Jyrki Eklund  CEO, Aino Health  Phone: +358 40 042 4221  jyrki.eklund@ainohealth.com   Certified adviser  Erik...

Continue reading

Cargotec’s financial statements review 2022 to be published on Thursday, 2 February 2023

CARGOTEC CORPORATION, PRESS RELEASE, 19 JANUARY 2023 AT 9:30 AM (EET) Cargotec’s financial statements review 2022 to be published on Thursday, 2 February 2023 Cargotec Corporation will publish its financial statements review 2022 on Thursday, 2 February 2023 at approximately 9:00 a.m. EET. The report will be available at www.cargotec.com after publication. A live international telephone conference for analysts, investors and media will be arranged on the publishing day at 10:00 a.m. EET. The event will be held in English. The report will be presented by CEO Mika Vehviläinen and CFO Mikko Puolakka. The presentation material will be available at www.cargotec.com by the latest 9:30 a.m. EET. To ask questions, please join the teleconference by registering via the following link: https://palvelu.flik.fi/teleconference/?id=1009459. After the...

Continue reading

Trading update for the three months ended 31 December 2022

PayPoint PlcTrading update for the three months ended 31 December 20221 19 January 2023 A positive quarter across the PayPoint Group with accelerated revenue growth across all three divisions Nick Wiles, Chief Executive of PayPoint Plc, said: “This has been another positive quarter for the PayPoint Group where net revenue growth has accelerated across all three of our business divisions, consistent with a more H2 weighted performance. We remain confident in delivering further progress in the current year, whilst our continued focus remains on the delivery of our strategic priorities, a strong operational performance and maintaining a tight control of our cost base. In Shopping, we continue to enhance our retailer partner proposition, with the further rollout of a number of key initiatives including Counter Cash, a growing contribution...

Continue reading

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial

Pivotal Phase III IMbrave050 study investigating Tecentriq plus Avastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of recurrence-free survival New adjuvant treatments are urgently needed as an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery1 Data will be discussed with health authorities globally, including the US Food and Drug Administration and the European Medicines Agency to inform the next regulatory steps, and presented at an upcoming medical meetingBasel, 19 January 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMbrave050 study met its primary endpoint of recurrence-free survival (RFS) at the prespecified interim analysis. The study is evaluating Tecentriq® (atezolizumab)...

Continue reading

Addex Provides Corporate Update and Financial Guidance

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 19, 2023 – Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today provided a corporate update, including a review of its pipeline and financial guidance. “We ended 2022 with CHF7.0 million of cash and expect to be able to finance our operations until Q3 2023. We continue to focus on entering into collaborative arrangements across our pipeline to secure the financial resources to advance their development and strengthen our balance sheet,” said Tim Dyer, CEO of Addex. “We also look forward to our Partner Janssen completing part 1 of the Phase 2 epilepsy study this quarter and reporting progress under our collaboration with Indivior.” Corporate Update:Cash...

Continue reading

Nokia to publish fourth-quarter and full-year 2022 financial report and provide Group Progress Update on 26 January 2023

Press Release Nokia to publish fourth-quarter and full-year 2022 financial report and provide Group Progress Update on 26 January 2023 19 January 2023 Espoo, Finland – Nokia will publish its fourth-quarter and full-year 2022 financial results on 26 January 2023 at approximately 8 a.m. Finnish time (EET). The financial report will be made available on the Nokia website immediately after publication. Nokia only publishes a summary of its financial reports in stock exchange releases. The summary focuses on Nokia Group’s financial information as well as on Nokia’s outlook. The detailed, segment-level discussion will be available in the complete financial report hosted at www.nokia.com/financials. A video interview summarizing the key points of our Q4 results will also be published on the website. Investors should not solely rely...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.